![Charles Cotropia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Cotropia
Corporate Officer/Principal chez
State Bar of Texas
Profil
Charles S.
Cotropia was the founder of Bioclonetics Immunotherapeutics, Inc. (founded in 2009) where he served as the Chief Executive Officer & Director from 2009 to 2020.
He is currently the President & Director at Biogenysis, Inc. and a Member of the State Bar of Texas.
Previously, he was the President, Chief Executive Officer & Director at Enzolytics, Inc. from 2020 to 2024.
He also held the position of Director at the Dallas Bar Association.
Prior to that, he worked as Senior Counsel at Sidley Austin LLP from 1973 to 2015.
Mr. Cotropia obtained his undergraduate degree from The University of Texas at Austin and his graduate degree from Cornell University.
Postes actifs de Charles Cotropia
| Sociétés | Poste | Début |
|---|---|---|
State Bar of Texas
 State Bar of Texas Miscellaneous Commercial ServicesCommercial Services Provides legal educational programming services | Corporate Officer/Principal | - |
Anciens postes connus de Charles Cotropia
| Sociétés | Poste | Fin |
|---|---|---|
| ENZOLYTICS, INC. | Directeur Général | 19/03/2024 |
Biogenysis, Inc.
 Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of species specific monoclonal antibodies against diseases | President | 23/02/2024 |
Bioclonetics Immunotherapeutics, Inc.
 Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops human neutralizing monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy | Fondateur | 01/12/2020 |
Sidley Austin LLP
 Sidley Austin LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Conseiller Juridique Général | 01/01/2015 |
Dallas Bar Association
 Dallas Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as an association of attorneys | Directeur/Membre du Conseil | - |
Formation de Charles Cotropia
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dallas Bar Association
Dallas Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as an association of attorneys | Commercial Services |
State Bar of Texas
State Bar of Texas Miscellaneous Commercial ServicesCommercial Services Provides legal educational programming services | Commercial Services |
Enzolytics, Inc.
 Enzolytics, Inc. BiotechnologyHealth Technology Develops and commercializes of drugs for infectious disease treatments | Health Technology |
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops human neutralizing monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy | Health Technology |
Sidley Austin LLP
Sidley Austin LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of species specific monoclonal antibodies against diseases | Commercial Services |
